Serum endocan levels in patients with chronic obstructive pulmonary disease: a potential role in the evaluation of susceptibility to exacerbation

Clin Chem Lab Med. 2018 Nov 27;56(12):e295-e297. doi: 10.1515/cclm-2018-0331.

Authors

Maria Kechagia^{1

2}, Kalliopi Michalakakou², Khristina Griniouk³, Andriani Piante³, Napoleon Karagiannidis³, Vassiliki Filaditaki³, Zoe Daniil¹, Ioannis Papassotiriou², Konstantinos I Gourgoulianis¹

Affiliations

¹ Respiratory Medicine Department, University of Thessaly Medical School, Larissa, Greece.
² Department of Clinical Biochemistry, Aghia Sophia Children's Hospital, Athens, Greece.
³ 2nd Respiratory Medicine Department, Sismanoglio-A. Fleming General Hospital, Athens, Greece.

PMID: 29858900
DOI: 10.1515/cclm-2018-0331

No abstract available

Keywords: chronic obstructive pulmonary disease (COPD); endocan; endothelial dysfunction; exacerbations.

Publication types

Letter

MeSH terms

Biomarkers / blood
Humans
Neoplasm Proteins / blood*
Proteoglycans / blood*
Pulmonary Disease, Chronic Obstructive / blood*

Substances

Biomarkers
ESM1 protein, human
Neoplasm Proteins
Proteoglycans